The American Society of Clinical Oncology released an update to their guideline for geriatric oncology, focused on the practical assessment and management of vulnerabilities in older patients receiving chemotherapy.
ASCO Updates Guideline for Assessment, Management of Vulnerabilities in Older Patients Undergoing Chemo
A new study sought to better define real-world initiation, management, and outcomes of patients with chronic lymphocytic leukemia treated with a standard-of-care therapy.
A recent study analyzed the effects of implementing a clinical pathway for thyroid cancer in a hospital setting.
Dawn Holcombe, MBA, FACMPE, ACHE, explains why private payers are making the transition from traditional reimbursement models to value-based models at a slow pace and how OCM performance results may impact this transition.
Opioid Epidemic, 340B Drug Discount Program Substantially Impact Patients, Community Oncology Practices
Debra Patt, MD, MPH, MBA, spoke about the major issues affecting patients with cancer and community practices in the United States.
A recent study sought to determine if clinical benefits of novel anticancer drugs have increased over time in conjunction with increasing costs.
Robin T Zon, MD, FACP, FASCO, and Bobby Daly, MD, MBA, discuss ASCO's recently published results of an evaluation of national pathway vendors against the Criteria for High-Quality Clinical Pathways.
Multidisciplinary Roundtable Discussion Focuses on Emerging Issues in Value-Based Health Care Models
Following the dual-keynote presentations given by Ron Kline, MD, FAAP, and Lee N Newcomer, MD, MHA, a lively roundtable discussion took place on the NCCN stage regarding critical current and emerging issues in the delivery of cancer care in value-based care models.
The second presentation of the NCCN Annual Conference Keynote session was given by Lee N Newcomer, MD, MHA, a leading voice in the payer community, who spoke on cancer care delivery from the managed care perspective.
Texas Oncology and Aetna partnered to provide a practice-based program that reduced costs while maintaining adherence to treatment pathways and patient satisfaction in Medicare patients.